Bloomberg BNA Law Reports deliver essential and reliable commentary and analysis on legislative, regulatory, and judicial developments affecting the health care industry. Health-related titles include BNA’s Health Care Daily Report™, BNA’s Health Law Reporter™, Pharmaceutical Law & Industry Report®, and Health Care Fraud Report™.
Gain valuable perspective and access detailed analysis from a wide range of in-depth Bloomberg BNA Portfolios. Our library of Portfolios covers topics such as business & taxation, health care fraud and abuse compliance, health insurance and benefits, hospitals and provider regulation, and pharmaceuticals and life sciences. Specific titles include Health Care Mergers and Acquisitions: The Antitrust Perspective and Federal Anti-Kickback Law. Browse or search a Portfolio’s table of contents and move easily from section to section using the easy-to-navigate document headings.
Take advantage of extensive regulatory materials, including recent decisions and guidance from regulatory agencies such as the U.S. Department of Health & Human Services (HHS) and the Food & Drug Administration (FDA). Resources include Centers for Medicare & Medicaid Services (CMS) Manuals and Transmittals, FDA warning letters and guidance for industry, and HHS Office of Inspector General Advisory Opinions and Corporate Integrity Agreements.
AMERICAN BAR ASSOCIATION
GETTING THE DEAL THROUGH
PRACTISING LAW INSTITUTE